The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
464 Hillside Ave.
Needham, MA 2494
The Boston Foundation for Sight (BFS) is a world renowned nonprofit eye health care organization. Their mission is to improve the quality of life for patients and their families by transforming the understanding, treatment and care of complex corneal disease. Since 1992 BFS has restored sight to thousands of patients from around the world through the use of BostonSight PROSE, a treatment to restore the vision of patients with complex corneal disease, enabling them to reclaim their lives. During PROSE treatment doctors custom design and fit prosthetic devices to replace or support damaged ocular functions; improving vision and reducing pain and light sensitivity. BostonSight PROSE treatment is available at top-ranked academic medical centers and clinics around the world through the PROSE Provider Network.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.